ClinicalTrials.gg
Not yet recruitingNCT07525154Updated Apr 13, 2026

Development of a Certified Testing Procedure for Hip and Groin Injuries in Athletes

An interventional study of Strength-focused and Flexibility-focused in Hip Injury, sponsored by Charles University, Czech Republic. Not yet recruiting. Open to participants aged 14 Years to 20 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by Charles University, Czech Republic · Not applicable, Interventional, and Screening

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
170
Allocation
Randomized
Ages
14 Years to 20 Years
Sex
All
01

Study summary

Hip and groin injuries affect approximately 21% of professional athletes annually, causing significant time loss. As roughly 48% of these cases result from non-contact mechanisms, they are potentially preventable through optimized diagnostic screening. Evidence strongly links restricted hip range of motion (ROM) and strength deficits to an increased injury risk. This project aims to (1) develop a rigorously validated diagnostic testing procedure by comparing different joint positions, movement velocities, and muscle contractions to establish a preventive "gold standard" screening battery. dditionally, (2) pilot targeted prevention interventions over a competitive season. Using a crossover design, the research evaluates three protocols: Strength-focused,Flexibility-focused:and control group. (3) Implement of a Centralized Injury Reporting System. Combining comprehensive diagnostic screening with these practical interventions will yield a powerful tool for clinicians and coaches to effectively reduce the incidence and burden of non-contact hip and groin injuries

02

Conditions studied

  • Hip Injury

Browse trials for

03

In context

Hip Injuries

66 studies on the registry are indexed under Hip Injuries; 12 are open to participants now.

This study's planned enrollment of 170 is above the median of 61 across 40 interventional studies indexed under Hip Injuries.

Browse Hip Injuries studies →

Lead sponsor

Charles University, Czech Republic is the lead sponsor of 228 studies on the registry; 76 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 20 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female competitive team sports.
  • Registered members of participating team sports.
  • Age 14 to 20 years.
  • Participation in regular team training and competition during the study period.
  • Medically cleared for full participation in training and match play at study entry.
  • Willing and able to complete preseason testing and the assigned intervention program.
  • Provided written . For participants younger than 18 years, parent or legal guardian consent will also be obtained.

Exclusion criteria

Exclusion Criteria:

  • Current hip or groin injury causing time loss or restricting full participation in training or competition at baseline.
  • Lower extremity or lumbar spine injury at baseline that limits safe participation in testing or intervention exercises.
  • Surgery involving the hip, groin, pelvis, lumbar spine, or lower extremity within the previous 6 months.
  • Any neurological, musculoskeletal, cardiovascular, or other medical condition that would contraindicate participation in the intervention or testing procedures.
  • Inability to complete baseline assessments.
  • Planned absence during a substantial part of the preseason intervention period or competitive season.
  • Noncompliance with study procedures or refusal to provide consent.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
170 participants (estimated)

Study arms

  • Experimental
    Strength-focused

    Emphasizing specific joint stabilization and eccentric load tolerance, heavily utilizing the Copenhagen Adductor Exercise.

    Other: Strength-focused

  • Experimental
    Flexibility-focused:

    Targeting functional hip ROM through stretching and dynamic mobility under load.

    Other: Flexibility-focused

  • No intervention
    Control

    Maintaining standard club warm-up and training regimens.

Interventions

  • OtherStrength-focused

    Emphasizing specific joint stabilization and eccentric load tolerance, heavily utilizing the Copenhagen Adductor Exercise.

  • OtherFlexibility-focused

    Targeting functional hip ROM through stretching and dynamic mobility under load.

06

What researchers measure

Primary outcomes

  1. Hip and Groin Injury Incidence During the Competitive Season

    The number of new hip and groin injuries occurring during the monitored competitive season among athletes participating in the different preseason intervention programs. Injury incidence will be recorded by team medical staff and expressed as the number of injuries per 1000 athlete-exposures.

    Time frame: Through the competitive season, up to 9 months

Secondary outcomes

  1. Hip and Groin Injury Severity

    Severity of hip and groin injuries assessed as the number of days lost from training or competition following injury.

    Time frame: Through the competitive season, up to 9 months

  2. Hip and Groin Injury Burden

    Overall injury burden calculated as the product of injury incidence and injury severity across the study period.

    Time frame: Through the competitive season, up to 9 months

  3. Change in Hip Range of Motion (ROM)

    Passive hip range of motion assessed using standardized clinical ROM testing (Bent Knee Fall-Out test and passive hip flexion/abduction assessments) with a digital inclinometer.

    Time frame: Baseline (Day 1, preseason screening) and 8 weeks (end of preseason intervention)

  4. Functional Lower Limb Performance

    Functional performance of the lower extremity assessed through a standardized testing battery evaluating strength, mobility, and sport-specific functional performance.

    Time frame: Baseline (preseason) and post-intervention (end of preseason)

  5. Hip Adduction and Abduction Strength

    Hip adduction and abduction peak torque measured using isokinetic dynamometry (Humac Norm or Biodex system) during concentric and eccentric contractions at standardized angular velocities (30°/s, 120°/s).

    Time frame: Baseline (Day 1, preseason screening) and 8 weeks (end of preseason intervention)

  6. Isometric Hip Strength

    Isometric hip adduction strength measured using hand-held dynamometry (HHD) squeeze tests and fixed dynamometry systems such as ForceFrame/GroinBar at joint angles of 0°, 25°, and 50° hip abduction.

    Time frame: Baseline (Day 1, preseason screening) and 8 weeks (end of preseason intervention)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Dec 2031, 59 months later.

Of 26 non-industry interventional studies with no phase under Hip Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 65. This study's planned 59 months is above that.

Counting every sponsor, half of 28 studies reached it within 26 months; a quarter within 8 and three quarters within 65.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2026
First posted
Apr 13, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Dec 31, 2031
CompletionEst.
Dec 31, 2031
Last update
Apr 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07525154
Responsible party
Anna Pisz (PT., Ph.D., Charles University, Czech Republic) — Principal investigator
First posted
Apr 13, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Dec 31, 2031 (estimated)
Completion
Dec 31, 2031 (estimated)
Last update
Apr 13, 2026

Study contacts

Anna Pisz, PT, PhD
Contact
anna.pisz@ftvs.cuni.cz
+420703952913

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion